Kenneth J. Kelley, Director at HALOZYME THERAPEUTICS, INC. (HALO), sold 9,754 shares at $48.09 ($469K) on 2021-02-01, disclosed to the SEC on 2021-02-01.
Open-market sale of $469k HALO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.09 | 4,754 | $229K | 48.7% |
| 2 | $48.09 | 4,754 | $229K | 48.7% |
| 3 | $48.69 | 246 | $12K | 2.6% |
| Total | $48.11 avg | 9,754 | $469K | 100% |
| Filing → |
| HALO | SELL | 2021-01-04 | $417K | — | Filing → |
| HALO | SELL | 2020-12-07 | $1.4M | — | Filing → |
| HALO | SELL | 2020-12-02 | $1.3M | — | Filing → |